BioMed Realty Trust (BMR) Posts Q3 EPS of $0.32, In-Line with Street
More News related to BMR
- BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million
- BioMed Realty Commences Tender Offer for Its Exchangeable Notes
- RBC Capital Upgrades BioMed Realty Trust (BMR) to Sector Perform
- BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals
- BioMed Realty Trust (BMR) Posts Q3 EPS of $0.32, In-Line with Street
More News related to Earnings
- Shields & Co. Downgrades ALLETE, Inc. (ALE) to Hold
- Scotia Capital Downgrades Grupo Aeroportuario del Centro (OMAB) to Sector Perform
- Goldman Sachs Upgrades Bradesco and Banco do Brasil; Downgrades Bancolombia
- Wedbush Downgrades Burger King (BKC) to Underperform
- Morgan Stanley Upgrades Safeway (SWY), Downgrades SUPERVALU (SVU)
BioMed Realty Trust Inc. (NYSE: BMR) reports Q3 EPS of $0.32, in-line with the analyst estimate of $0.32. Revenue for the quarter was $92.96 million, which compares to the estimate of $85.66 million.
Related Categories
EarningsStocks Mentioned
+0.57Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
